gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

Mesothelioma is an aggressive cancer of the serous membranes with poor prognosis despite combination therapy consisting of surgery, radiotherapy, and platinum-based chemotherapy. Targeted therapies, including immunotherapies, have reported limited success, suggesting the need for additional therapeu...

Full description

Bibliographic Details
Main Authors: Ellinor Peerschke, Kenneth Stier, Xiaoyu Li, Evelyn Kandov, Elisa de Stanchina, Qing Chang, Yuquan Xiong, Katia Manova-Todorova, Ning Fan, Afsar Barlas, Berhane Ghebrehiwet, Prasad S. Adusumilli
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
mesothelioma
complement
gC1qR/HABP1/p32
monoclonal antibody therapy
therapeutic target
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01413/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01413/full

Similar Items